Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
Conditions: Type 2 Diabetes Mellitus in Obese; Heart Failure With Preserved Ejection Fraction Interventions: Drug: Pioglitazone; Drug: Placebo Sponsor: The University of Texas Health Science Center at San Antonio Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actos | Cardiology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Heart | Heart Failure | Obesity | Research | Science | Texas University